For sublingual formulations specifically, the oral mucosal absorption pathway avoids first-pass metabolism through the liver, which may influence how the compound behaves in the body
And there, there, as you know, there are reasons to do both
Santos LB et al
Para um melhor entendimento, entre as medicaes aprovadas no Brasil pela ANVISA para tratamento da obesidade semaglutida (Princpio ativo presente no Wegovy, Ozempic, Rybelsus), liraglutida (Princpio ativo presente no Victoza e Saxenda), contrave, sibutramina e orlistate nenhuma apresenta taxa de perda de peso mdia superior a 20% em pesquisas clnicas
This third pathway introduces additional metabolic effects that may explain Retatrutides superior weight loss numbers in clinical trials
That requires patience, structure, and self-compassion